A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

January 20, 2025

Study Completion Date

January 20, 2025

Conditions

Pain

Interventions

DRUG

HRS-2129

DRUG

HRS-2129 Placebo

Trial Locations (1)

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06619392 - A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects | Biotech Hunter | Biotech Hunter